Tag: drug delivery devices market analysis

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Drug Delivery Devices Market Size from 2025 to 2034?

In recent times, there has been a robust growth in the drug delivery devices market. It is projected that this market, which was valued at $91.03 billion in 2024, will ascend to $95.99 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%. The surge observed in the historic period can be credited to a swift increase in aging population, expansion in healthcare facilities, economic enhancement in the developing markets, and rise in healthcare spending.

The market for drug delivery devices is anticipated to experience robust expansion in the forthcoming years. The market value is projected to reach $122.16 billion in 2029, with a compound annual growth rate (CAGR) of 6.2%. The expansion during this forecast period can be ascribed to the escalating prevalence of chronic diseases, the increased demand for injectables, a surge in the need for drug delivery devices, and the sudden outbreak of severe infections. Significant trends for this forecast period encompass investment in microneedle drug technology for medicine delivery, the exploration and creation of self-injectable drug delivery devices, a focus on mergers and acquisitions and investments in wearable drug delivery devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Drug Delivery Devices Market?

The escalating occurrence of chronic illnesses such as cardiovascular disease, diabetes, cancer and other ailments looks set to propel the market for drug delivery devices. As noted by the National Library of Medicine, a medical library in the US operated by the federal government, the population of individuals in the United States aged 50 and above with at least one chronic condition is anticipated to soar by 99.5% in January 2023. This surge will elevate the number from 71.522 million in 2020 to 142.66 million by 2050. There are diverse drug administration paths for medical drugs and the invention of novel drug delivery systems holds a considerable place in the pharmaceutical sphere. Due to the rising occurrence of these diseases, worldwide research and development (R&D) in drug delivery is on the upswing. Numerous pharmaceutical firms are directing their attention to several drug delivery technologies to achieve superior advantages and improved results for their marketed products. Therefore, the rising occurrence of chronic illnesses is leading to a heightened intake of therapeutic drugs and therapies, which is anticipated to serve as a catalyst for the expansion of the drug delivery devices market.

Which Primary Segments of the Drug Delivery Devices Market Are Driving Growth and Industry Transformations?

The drug delivery devicesmarket covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Drug Delivery Devices Market?# Market?

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Drug Delivery Devices Market?

Key players in the drug delivery device market, such as major companies, are concentrating their efforts on creating groundbreaking devices like autoinjectors with fully integrated connectivity to maintain their competitive advantage. Autoinjectors are engineered for individual self-administration of a preset medication dosage. For example, in May 2022, Jabil Healthcare, a US-based healthcare manufacturing solutions provider, unveiled the Qfinity autoinjector platform, a recyclable drug delivery tool. Differentiating itself with its simpler, reusable and modular design, the Qfinity autoinjector platform provides an affordable alternative to rivals in the market and encourages eco-friendly drug administration within the pharmaceutical sector. Its flexible design can handle different volumes and viscosities of pharmaceuticals, and it includes a patient-friendly structure that delivers up to 65% lower injection costs compared to top disposable autoinjectors. The robust Qfinity tool can perform over 100 injections and can use 1 mL or 2.25 mL pre-loaded disposable cassettes. Moreover, its lower component usage and decreased material use result in an estimated 65% reduction in injection costs, a 60% smaller carbon footprint, a 50% decrease in manufacturing footprint, and a 70% drop in capital expenditure (CAPEX).

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

What Parameters Are Used to Define the Drug Delivery Devices Market?

Drug delivery devices are used to deliver specific drugs to a specific part of the body to cure diseases. Drug delivery devices used in various patient care settings, such as hospitals, diagnostic centers, clinics, and home care settings, are included in this market.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Forecast for the Drug Delivery Devices Market from 2024 to 2025?#_x000D_

There’s been significant growth in recent years in the market size for drug delivery devices. It’s predicted to expand from $91.03 billion in 2024 to $96.73 billion in 2025, presenting a compound annual growth rate (CAGR) of 6.3%. The surge during the historic timeframe is linked to factors such as the fast-aging population, an increase in the quantity of healthcare facilities, emerging market economies, and higher healthcare spending._x000D_

_x000D_

#What Is the Projected Market Size of the Drug Delivery Devices Market?#_x000D_

The market for drug delivery devices is projected to experience robust growth in the coming years, escalating to $124.82 billion by 2029 at a CAGR of 6.6%. This growth during the projected timeframe can be credited to the rising occurrence of chronic diseases, an upward trend in demand for injectables, increased need for drug delivery devices, and the abrupt rise of severe infections. The primary trends anticipated during the forecast period involve investments in microneedle drug delivery technology, the pursuit of research and development in self-injectable drug delivery devices, a focus on mergers and acquisitions, and investments in wearable drug delivery devices._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp_x000D_

_x000D_

#Who are the Major Competitors in the Drug Delivery Devices Market Outlook?#_x000D_

Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc_x000D_

_x000D_

#What Is Fueling Growth in the Drug Delivery Devices Market?#_x000D_

The escalating occurrence of chronic illnesses such as heart disease, diabetes, cancer, and other ailments is projected to propel the drug delivery devices market forward. For example, the National Library of Medicine, a U.S.-based federally operated medical library, reported in January 2023 that the count of individuals in the United States aged 50 and older with one chronic ailment at least is expected to surge by 99.5%. This surge would raise the count from 71.522 million in 2020 to 142.66 million by 2050. There are many modes of administering medication for medical drugs. The innovation of new drug delivery systems is crucial in the pharmaceutical sector. Worldwide, research and development (R&D) in drug delivery are growing due increase in these diseases. The majority of pharmaceutical companies are prioritizing various drug delivery technologies to yield superior benefits and improved results for their marketed products. Consequently, the rising occurrence of chronic diseases that result in an increased use of therapeutic drugs and therapies is anticipated to serve as a catalyst for the expansion of the drug delivery devices market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp_x000D_

_x000D_

#Which Drug Delivery Devices Market Segments Are Growing the Fastest?#_x000D_

The drug delivery devices market covered in this report is segmented –_x000D_

_x000D_

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery_x000D_

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings_x000D_

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets_x000D_

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps_x000D_

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders_x000D_

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems_x000D_

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers_x000D_

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops_x000D_

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films_x000D_

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants_x000D_

_x000D_

#Which Industry Trends Are Shaping the Future of the Drug Delivery Devices Market?#_x000D_

Leading businesses in the drug delivery device market are concentrating their efforts on creating groundbreaking devices like autoinjectors that are fully integrated with connectivity in order to excel in the market. Autoinjectors are specialized devices intended for individual application of a predetermined medication dosage. To illustrate, Jabil Healthcare, a healthcare manufacturing solutions provider based in the US, rolled out the Qfinity autoinjector platform, a reliable reusable drug delivery device, in May 2022. The Qfinity platform distinguishes itself as an uncomplicated, reusable, and modular approach to self-administering subcutaneous drugs. It provides an economical alternative to market rivals, advancing sustainable drug distribution in the pharmaceutical sector. Its adaptable design adapts to different drug volumes and viscosities. The patient-friendly design allows for up to 65% reduction in the cost per injection compared to top disposable autoinjectors on the market. The robust Qfinity device is capable of supporting over 100 injections and uses 1 mL or 2.25 mL prefilled disposable cassettes. Furthermore, it reduces the usage of components and materials which leads to an estimated 65% drop in cost per injection, a 60% smaller carbon footprint, 50% shrinkage in manufacturing footprint, and a 70% cutback in capital expenditure (CAPEX)._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report_x000D_

_x000D_

#Which Countries Are Leading the Drug Delivery Devices Market?#_x000D_

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the drug delivery devices market, and how is it changing globally?_x000D_

2. Who are the major companies in the drug delivery devices market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the drug delivery devices market right now?_x000D_

4. Which products or customer segments are growing the most in the drug delivery devices market?_x000D_

5. What factors are helping or slowing down the growth of the drug delivery devices market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theDrug Delivery Devices Market?

The escalating occurrence of chronic illnesses such as heart diseases, diabetes, cancer, and other ailments is projected to propel the drug delivery devices market. For example, the National Library of Medicine, a medical library run by the US federal government, predicted in January 2023 that the population aged 50 and above in the United States with at least one chronic disease would see an increase by 99.5%. The prediction suggests a jump from 71.522 million in 2020 to 142.66 million by 2050. There are many ways to administer medical drugs, and the creation of advanced drug delivery systems is crucial to the pharmaceutical sector. As these diseases become more widespread, there is a worldwide increase in research and development (R&D) focused on drug delivery. The majority of pharma companies are putting their efforts into several drug delivery technologies to achieve superior benefits and improved results for their products on the market. Consequently, the escalating prevalence of chronic illnesses is leading to higher usage of therapeutic drugs and treatments, a factor that is anticipated to be a key driver for the expansion of the drug delivery devices market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

#What Growth Opportunities Will Drive the Drug Delivery Devices Market’s CAGR Through 2034?

The market for drug delivery devices has seen robust growth in the past few years. The market will expand from $91.03 billion in 2024 to approximately $96.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. This historical growth trend can be attributed to several factors, such as the rapid increase in the elderly population, the rising number of healthcare institutions, economic development in emerging markets, and increased spending on healthcare.

Expectations are high for the drug delivery devices market to experience significant growth in the coming years. By 2029, it is projected to reach a market size of $124.82 billion, with a compound annual growth rate (CAGR) of 6.6%. The projected growth in this period is primarily due to an increased prevalence of chronic illnesses, rising demand for injectables, increased requirement for drug delivery devices, and the sudden surfacing of severe infections. Forecasted trends for this period include investments in microneedle drug technology for medication delivery, concerted research, and development efforts for self-injectable drug delivery systems, a focus on mergers and acquisitions, and investments in wearable drug delivery devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

Which Cutting-Edge Market Trends Are Expected to Drive the Drug Delivery Devices Market’s Growth?

Top firms in the drug delivery device market are concentrating on the creation of groundbreaking devices such as autoinjectors integrated with complete connectivity to achieve a competitive advantage. Autoinjectors are healthcare devices intended for self-administration of a preset drug dose. For instance, Jabil Healthcare, an American healthcare manufacturing solutions company, introduced the Qfinity autoinjector platform in May 2022. This reusable drug delivery device is a simple, reusable, and modular approach to self-administer subcutaneous medication, presenting a financial savvy alternative to rival products and supporting sustainable drug delivery in the pharmaceutical sector. Its adaptable design caters to different drug amounts and thickness, and it features a patient-friendly design that offers up to 65% less cost per injection than popular disposable autoinjectors. The robust Qfinity device is good for over 100 injections and employs 1 mL or 2.25 mL pre-filled expendable cassettes. Additionally, the diminished component and material usage leads to an estimated 65% decrease in cost per injection, a 60% reduction in carbon footprint, a 50% decrease in manufacturing footprint, and a 70% fall in capital expenditure (CAPEX).

What Are the Leading Market Players Impacting theDrug Delivery Devices Market’s Growth Trend?

Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

How Are the Key Segments of the Drug Delivery Devices Market Driving Opportunities and Innovations?

The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theDrug Delivery Devices Market?# Market Expansion?

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Drug Delivery Devices Market 2025, By The Business Research Company:

Drug Screening Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Medical Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

Implantable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the drug delivery devices market size evolved in recent years?

The market size of drug delivery devices has seen robust growth in the past few years. Its size is expected to increase from $91.03 billion in 2024 to $96.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth in the historic period include the rapid increase in the aging population, expansion of healthcare facilities, economic expansion in developing markets, and a rise in healthcare spending.

What are the predictions for the drug delivery devices market size in the coming years?

The market size of farm machinery and equipment is anticipated to witness robust expansion in the upcoming years; the growth estimates suggest a surge to $295.1 billion by 2029 with a compound annual growth rate (CAGR) of 5.8%. Contributory factors to this growth during the projected period include advances in precision farming, robotics and automation, the Internet of Things (IoT) and data analytics, as well as eco-friendly farming solutions, and the utilization of electric and hybrid machinery. The future trends to look out for include the traceability provided by blockchain, the use of robotics in the harvesting and planting process, adoption of hydroponics and aeroponics technologies, implementation of multi-functional tools, and remote monitoring and controlling methods.

Get your drug delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

What key factors are fueling the growth of the drug delivery devices market?

The escalating occurrence of chronic illnesses such as cardiovascular diseases, diabetes, cancer and other ailments is anticipated to fuel the growth of the drug delivery devices market. For example, data from the National Library of Medicine, a US-based medical library governed by the federal government, in January 2023 projected a 99.5% surge in Americans aged 50 and above with at least one chronic disease. The numbers are expected to jump from 71.522 million in 2020 to 142.66 million by 2050. Diverse methods are employed for the administration of medical drugs. The invention of new drug delivery systems is a vital process in the pharmaceutical industry. Globally, there is a rise in research and development (R&D) in drug delivery due to the rising occurrence of these diseases. A majority of the pharmaceutical firms are concentrating on developing various drug delivery technologies to ensure superior benefits and improved results for their marketed products. Therefore, the escalating occurrence of chronic illnesses leads to a surge in the utilization of therapeutic drugs and therapies, which in turn, is anticipated to drive the growth of the drug delivery devices market.

How is the global drug delivery devices market divided into key segments?

The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

Who are the key firms paving the way for growth in the drug delivery devices market?

Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Which trends are expected to transform the drug delivery devices market?

Major drug delivery device market players are concentrating on the innovation of devices such as autoinjectors with fully integrated connectivity for a competitive advantage in the industry. Autoinjectors, designed for self-medication with coordinated doses, are rapidly evolving. For instance, Jabil Healthcare, based in the US and known for its healthcare manufacturing solutions, introduced the Qfinity autoinjector platform in May 2022. This reusable drug delivery device stands distinguished as a straightforward, reusable, and modular solution for self-injection of subcutaneous drugs. It serves as a cost-effective rival to other market players while endorsing sustainable medicine delivery in the pharmaceutical sector. The device’s adaptable design accommodates diverse drug volumes and viscosities, and its patient-friendly design leads to up to 65% lesser expenditure per injection compared to top disposable autoinjectors. The robust Qfinity device is capable of over 100 injections using 1 mL or 2.25 mL pre-loaded disposable cassettes. Besides, with reduced component and material usage, it offers an estimated cost reduction of 65% per injection, a 60% smaller carbon footprint, a 50% production footprint reduction, and a 70% decrease in capital expenditure (CAPEX).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

What regions are contributing significantly to the growth of the drug delivery devices market?

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Drug Screening Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Medical Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

Implantable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Rapidly is the Drug Delivery Devices Market Expected to Expand Between 2025 and 2034 Based on Current Trends?

The drug delivery devices market has shown strong growth in recent years. It is forecasted to increase from $91.03 billion in 2025 to $96.73 billion in 2025, at a CAGR of 6.3%. The historical growth is due to a rapidly aging population, expansion of healthcare facilities, economic growth in emerging markets, and increased healthcare expenditures.

The drug delivery devices market is expected to grow strongly, reaching $124.82 billion by 2029, with a CAGR of 6.6%. Growth is driven by the increasing prevalence of chronic diseases, demand for injectables, and the emergence of severe infections. Trends will include microneedle drug technology, self-injectable devices, mergers and acquisitions, and wearable drug delivery devices.

What Drivers Are Shaping the Growth of the drug delivery devices Market?

The increasing prevalence of chronic diseases like cardiovascular diseases, diabetes, and cancer is expected to propel the drug delivery devices market. For instance, the National Library of Medicine projects that the number of individuals aged 50 and older with chronic conditions in the U.S. will double by 2050. This growth in chronic disease prevalence is expected to drive demand for drug delivery devices.

Get Your Free Sample of the Global Drug Delivery Devices Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

Which Key Players Are Shaping the Future of the Drug Delivery Devices Market?

Major companies operating in the drug delivery devices market include:

• Becton_x000D_

• Dickinson and Company_x000D_

• Baxter International_x000D_

• B. Braun Melsungen AG_x000D_

• Catalent_x000D_

How Are the Latest Trends Influencing the Growth of the Drug Delivery Devices Market?

In the drug delivery device market, companies are developing innovative devices like autoinjectors with built-in connectivity. For instance, in May 2022, Jabil Healthcare launched the Qfinity autoinjector platform, a reusable device for subcutaneous drug self-administration. This modular device offers a cost-effective solution with up to 65% lower costs per injection and supports over 100 injections, promoting sustainability in the pharmaceutical industry.

Get Instant Access to the Global Drug Delivery Devices Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Which Key Market Segments Comprise the Drug Delivery Devices Market and Drive Its Revenue Growth?

The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

What Regions Are At the Forefront of Drug Delivery Devices Market Expansion?

North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can We Define the Drug Delivery Devices Market and Its Key Components?

Drug delivery devices are used to deliver specific drugs to a specific part of the body to cure diseases. Drug delivery devices used in various patient care settings, such as hospitals, diagnostic centers, clinics, and home care settings, are included in this market.

Browse Through More Similar Reports By The Business Research Company:

Drug Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Medical Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: